These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11994494)

  • 1. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance.
    Yin D; Ma L; Varghese A; Shen J; Chong AS
    J Immunol; 2002 May; 168(10):5352-8. PubMed ID: 11994494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allograft tolerance induced by intact active bone co-transplantation and anti-CD40L monoclonal antibody therapy.
    Yin D; Ma L; Zeng H; Shen J; Chong AS
    Transplantation; 2002 Aug; 74(3):345-54. PubMed ID: 12177612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.
    Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams JW; Byrne G; Diamond LE; Logan JS
    Xenotransplantation; 2000 Nov; 7(4):275-83. PubMed ID: 11081762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice.
    Yin D; Ma L; Shen J; Byrne GW; Logan JS; Chong AS
    Am J Transplant; 2002 Jan; 2(1):41-7. PubMed ID: 12095055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone.
    Yin D; Dujovny N; Ma L; Varghese A; Shen J; Bishop DK; Chong AS
    J Immunol; 2003 Jan; 170(2):853-60. PubMed ID: 12517950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
    Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
    J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.
    Ohdan H; Yang YG; Shimizu A; Swenson KG; Sykes M
    J Clin Invest; 1999 Aug; 104(3):281-90. PubMed ID: 10430609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation.
    Chong A; Blinder L; Ma L; Yin D; Shen J; Williams JW; Byrne G; Schwarz A; Diamond LS; Logan JE
    Transpl Immunol; 2000 Jun; 8(2):129-37. PubMed ID: 11005319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
    Ohdan H; Yang YG; Swenson KG; Kitamura H; Sykes M
    Transplantation; 2001 Jun; 71(11):1532-42. PubMed ID: 11435961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts.
    Kearns-Jonker M; Fischer-Lougheed J; Shulkin I; Kleihauer A; Mitsuhashi N; Kohn DB; Weinberg K; D'Apice AJ; Starnes VA; Cramer DV
    Transplantation; 2004 Jun; 77(11):1748-54. PubMed ID: 15201677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to gal oligosaccharides.
    Teranishi K; Gollackner B; Bühler L; Knosalla C; Correa L; Down JD; White-Scharf ME; Sachs DH; Awwad M; Cooper DK
    Transplantation; 2002 Jan; 73(1):129-39. PubMed ID: 11792992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
    Ohdan H; Swenson KG; Kitamura H; Yang YG; Sykes M
    Xenotransplantation; 2001 Nov; 8(4):227-38. PubMed ID: 11737848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
    Burns AM; Ma L; Li Y; Yin D; Shen J; Xu J; Chong AS
    J Immunol; 2009 Feb; 182(3):1314-24. PubMed ID: 19155477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection.
    Yin DP; Sankary HN; Ma LL; Shen J; Qin Y; Blinder L; Williams JW; Chong AS
    Transplantation; 2001 May; 71(10):1385-9. PubMed ID: 11391223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells.
    Nathan MJ; Yin D; Eichwald EJ; Bishop DK
    Am J Transplant; 2002 Apr; 2(4):323-32. PubMed ID: 12118853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
    van der Touw W; Burrell B; Lal G; Bromberg JS
    Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
    Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
    Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection.
    Xu H; Yin D; Naziruddin B; Chen L; Stark A; Wei Y; Lei Y; Shen J; Logan JS; Byrne GW; Chong AS
    J Immunol; 2003 Feb; 170(3):1531-9. PubMed ID: 12538718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.